Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer models.
Year: 2009
Type: article
Source: PubMed
Institution: Eli Lilly (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W129605
